Sclerostin levels in patients with acromegaly
Acromegaly is a rare, endocrine condition characterized by autonomous excessive secretion of growth hormone, causing numerous complications, including impairment of bone microarchitecture. The increased bone turnover observed in acromegaly can lead to bone fragility and elevated risk of vertebral fr...
Saved in:
| Main Authors: | Arnika Wydra, Jakub Wydra, Jagoda Rogowska, Wojciech Zgliczyński, Izabella Czajka-Oraniec |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-08-01
|
| Series: | Endokrynologia Polska |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/endokrynologia_polska/article/view/105450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of bone status and bone turnover in pediatric patients with familiar hypomagnesemia with hypercalciuria and nephrocalcinosis
by: Beata Bieniaś, et al.
Published: (2025-05-01) -
Association between bone turnover markers and FRAX predicted fracture risk in Chinese adults: a cross-sectional study
by: Xiaoli Qu, et al.
Published: (2025-05-01) -
Impact of elevated sclerostin levels on bone resorption: unravelling structural changes and mineral metabolism disruption
by: María Encarnacion Rodríguez-Ortiz, et al.
Published: (2025-05-01) -
BIOCHEMICAL BONE MARKERS AS PREDICTORS OF BONE LOSSES FOLLOWING LIVER TRANSPLANTATION
by: V. P. Buzulina, et al.
Published: (2010-06-01) -
Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment
by: Shi-Hsun Chiu, et al.
Published: (2024-12-01)